STAT+: Pharmalittle: FDA panel will scrutinize Novavax shot for Covid-19; J&J and Emergent accuse each other of breach
A FDA advisory panel is set to scrutinize the Novavax Covid-19 vaccine after months of delays and an agency review that found the shots effective but raised a safety concern.
Top of the morning to you, and a fine one it is. Blue skies and rays of sunshine are enveloping the Pharmalot campus, where the
